Application of radial basis function networks and successive projections algorithm in a QSAR study of anti-HIV activity for a large group of HEPT derivatives

被引:32
作者
Akhlaghi, Yousef
Kompany-Zareh, Mohsen [1 ]
机构
[1] Inst Adv Studies Basic Sci, Dept Chem, GavaZang 451951159, Zanjan, Iran
[2] Shiraz Univ Med Sci, Med & Nat Prod Chem Res Ctr, Shiraz, Iran
关键词
QSAR; anti-HIV; radial basis function networks; successive projections algorithm;
D O I
10.1002/cem.971
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
A series of 1-[2-hydroxyethoxy-methyl]-6-(phenylthio)thymine] (HEPT) derivatives, as normucloside reverse transcriptase inhibitors (NNRTIs), was investigated using a nonlinear quantitative structure-anti-HIV-1-activity relationship QSAR) study. Molecular descriptors derived solely from molecular structure were used to represent molecular structure. Utilizing successive projections algorithm (SPA) and a stepwise backward elimination, a subset of 11 descriptors were selected. Application of SPA minimizes the collinearity between the selected descriptors, which are known to be responsible for the anti-HIV-1 activity. Three layer radial basis function networks (RBFNs) were used to construct the nonlinear QSAR models in all stages of study. The relative standard error percent in anti-HIV activity predictions for the training set by the application of cross-validation (RSECV%) was 9.94%, and for prediction set (RSEP%) was 9.99%. The obtained model outperforms those given in the literature in both the fitting and predicting stages. RBFN analysis yielded predicted activities in the excellent agreement with the experimentally obtained values (cross-validation r = 0.927, prediction r = 0.925). Copyright (C) 2006 John Wiley & Sons, Ltd.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 61 条
[2]  
[Anonymous], EXPLORING QSAR FUNDA
[3]  
[Anonymous], MATLAB ROUTINES SUBS
[4]   The successive projections algorithm for variable selection in spectroscopic multicomponent analysis [J].
Araújo, MCU ;
Saldanha, TCB ;
Galvao, RKH ;
Yoneyama, T ;
Chame, HC ;
Visani, V .
CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, 2001, 57 (02) :65-73
[5]   HIGHLY SPECIFIC-INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 BY A NOVEL 6-SUBSTITUTED ACYCLOURIDINE DERIVATIVE [J].
BABA, M ;
TANAKA, H ;
DECLERCQ, E ;
PAUWELS, R ;
BALZARINI, J ;
SCHOLS, D ;
NAKASHIMA, H ;
PERNO, CF ;
WALKER, RT ;
MIYASAKA, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 165 (03) :1375-1381
[6]  
Baba Masanori, 1992, Drugs of the Future, V17, P891
[7]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[8]   QSAR for anti-HIV activity of HEPT derivatives [J].
Bazoui, H ;
Zahouily, M ;
Boulajaaj, S ;
Sebti, S ;
Zakarya, D .
SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2002, 13 (06) :567-577
[9]   ANTI-HIV AND CYTOTOXIC ALKALOIDS FROM BUCHENAVIA-CAPITATA [J].
BEUTLER, JA ;
CARDELLINA, JH ;
MCMAHON, JB ;
BOYD, MR .
JOURNAL OF NATURAL PRODUCTS, 1992, 55 (02) :207-213
[10]   Perspectives of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection [J].
De Clercq, E .
FARMACO, 1999, 54 (1-2) :26-45